Articles · Health
Fibromyalgia: what science has confirmed and which rights the law guarantees
The largest genetic study ever conducted on the condition reinforces its neurological basis. Learn what changes and what Brazilian law provides.
For many years, people with fibromyalgia were told that their pain “was psychological.” In July 2026, the journal Nature Medicine published the largest genetic study ever carried out on the condition, and the result points in another direction.
What the study found
Researchers from seven countries analyzed genetic data from 2,563,755 people, 54,629 of them diagnosed with fibromyalgia, drawn from 11 research databases. They identified 26 regions of the genome associated with the risk of the condition, several of them close to genes with neural functions. The heritability of fibromyalgia was concentrated exclusively in brain tissues and nervous system cells. For the authors, the data indicate that fibromyalgia is primarily a disorder of the nervous system.
What the study does not say
The researchers themselves warn that these genetic variants cannot be used for diagnosis and that genetics alone does not determine who develops the condition. Nor does the study offer an immediate new treatment. Its value lies in reinforcing, with data from millions of people, that the pain has a biological basis.
What Brazilian law provides
Law 15,176/2025 allows a person with fibromyalgia to be treated as equivalent to a person with a disability. This equivalence, however, is not automatic: it depends on a biopsychosocial assessment by a multidisciplinary team, as provided in the Statute of Persons with Disabilities (Law 13,146/2015). The diagnosis alone is not enough. Each case requires concrete evidence of the person's limitations.
Why documentation matters
Detailed medical reports, test results, treatment history and records of the impact of pain on work and daily life are the basis for administrative and court claims. Scientific studies such as this one can strengthen the legal reasoning, but they do not replace individual evidence.
Sources: Kerrebijn, I. et al. “The genetic architecture of fibromyalgia across 2.5 million individuals.” Nature Medicine, 2026. DOI 10.1038/s41591-026-04492-6. Law 15,176/2025; Law 13,146/2015; Agência Senado.
© 2026 Diego Amâncio Dias. Original text. Reproduction is permitted with credit to the source.